Agenus Inc (AGEN)
- Sector
- Biotechnology
- Last price
- $7.15
- As of
Kresmion compiles this page from AGEN's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
AGENUS INC (AGEN): 2 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-11-05.
See the full AGEN dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for AGEN on one page. Preview it with sample data, then open it live with a free account.
Preview the AGEN dossierActive events for AGEN
- mediumEarnings below estimates
Q2-2026: Missed consensus by 119.6%, EPS $-0.01 vs $0.051 estimate
- high13F: large increase
CITADEL ADVISORS LLC added +88% to AGEN (2026Q2)
- high13F: large increase
CITADEL ADVISORS LLC added +171% to AGEN (2026Q2)
- high13F: large reduction
MILLENNIUM MANAGEMENT LLC cut 81% of AGEN (2026Q1)
- high13F: large reduction
D. E. Shaw & Co., Inc. cut 74% of AGEN (2026Q1)
FREE, NO ACCOUNT
Every event on AGEN, as it fires
You are seeing 5 of 8 events recorded on AGEN since 2026-06-21.
The five above landed across 2 days. The other 3 were recorded on 1 other days. 4 of the 8 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
AGEN positions held by the managers we follow (2026Q2)
What the managers we follow bought and sold in Q2 2026
| Manager / security | Market value | % of reported value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC FundCUSIP 00847G804 · 2026Q2 | $699K | 0.00% |
| TWO SIGMA INVESTMENTS, LP FundCUSIP 00847G804 · 2026Q2 | $302K | 0.00% |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, AGEN
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Going concern statement
AGEN's 10-Q filed Nov 5, 2026 states:
…transactions are not entirely within our control, in accordance with applicable accounting standards, substantial doubt exists about our ability to continue as a going concern for at least one year after the date these condensed consolidated financial statements are issued.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on AGEN
AGEN against its peers
AGEN's operating margin of -17.7% ranks in the 68th percentile of 13 Biotechnology sub-industry peers, fiscal periods ending between 2025-09-30 and 2026-06-30.
| Metric | AGEN | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 114M USD | 53.7M USD | 97 | 15 |
| Operating margin | -17.7% | -212.9% | 68 | 13 |
| Net margin | -2.7% | -203.3% | 82 | 13 |
| Return on equity | n/a | -40.5% | n/a | 19 |
Peers (21): SABS, NAUT, QTTB, NWBO, RCKT, BNTC, IPSC, ANIK, GALT, ENTA, LYEL, LRMR, SPRY, BCYC, LCTX, ARCT, CUVL, XFOR, LXEO, ALEC, KYTX. Left out: VCRE (no annual filing), SCTX (no annual filing), EIKN (no annual filing), VOGX (no annual filing). Fiscal periods ending between 2025-09-30 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (AGEN: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in AGEN on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on AGEN in the last 180 days.
Upstream: SEC EDGAR filings for AGEN
Kresmion, "AGENUS INC (AGEN) institutional holdings and SEC filings", data as of 2026-11-05, https://kresmion.com/research/AGEN. Upstream data: SEC EDGAR filings for AGEN.
Link to this data (HTML):
<a href="https://kresmion.com/research/AGEN">AGENUS INC (AGEN) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow AGEN on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to AGEN for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.